REMDESIVIR NOW A PART OF COVID-19 THERAPY IS NEW HEALTH PROTOCOL

Remdesivir has been included as a part of investigational therapy by the Union Ministry of Health and has updated Clinical Management Protocol of Covid 19 patients. Loss of taste and smell has also been included in list of symptoms of covid 19 infection.
Under the new protocol the union health ministry has removed its earlier recommendation of the use of Hydroxychloroquine in severe cases and also the use of Hydroxychloroquine in combination with Azithromycin was removed. The new protocol includes the list of medicines that can be taken by patients suffering from Covid 19 such as Tocilizumab, Convalescent plasma therapy. CPT is a experimental treatment that is being used by some doctors on Covid 19 patients. Under this therapy the antibodies isolated from the Covid 19 recovered patients are injected into the affected people with the virus. The blood sample of people recovered from Covid 19 is called Convalescent Plasma.
This therapy is used on people who’s body is not responding to other drugs and are suffering from Acute Respiratory Distress Syndrome.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s